Serpin B-11 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Serpin B-11 (SERPINB11, UniProt Q96P15), expressed in HEK293 cells. Suited for antibody validation, protein–protein interaction studies, and expression profiling in ovarian cancer and liver injury research contexts.
Expression system
HEK293
Cat. #
REC-SerpinB11

In stock

SKU
REC-SerpinB11
$498.00

Target Overview

Serpin B-11 (UniProt Q96P15; gene SERPINB11) is a 392-amino-acid member of the clade B (ovalbumin-type) serpin superfamily, which characteristically localise to the cytoplasm and lack a classical signal peptide. Unlike the majority of clade B serpins, Serpin B-11 is annotated as a non-inhibitory serpin: structural variants within the scaffold are thought to prevent the conformational change required for canonical serine protease inhibition, placing it in the category of serpin homologues that may serve non-inhibitory, structural, or regulatory roles yet to be fully characterised. This recombinant is produced in HEK293 mammalian cells, covering the full 392-residue human sequence. Mammalian expression preserves native-like folding and post-translational processing relevant to studies of serpin conformation, protein–protein interactions, and cell-based assays — contexts where prokaryotic expression systems may yield misfolded product. Researchers use this recombinant primarily as a defined protein standard for antibody validation (Western blot and immunohistochemical titration), as a loading control antigen in dot-blot or slot-blot formats, and as a reference material for quantitative expression studies by ELISA. Because Serpin B-11 lacks confirmed protease inhibitory activity, functional activity assays against serine protease substrates are not a validated application; researchers interested in expression-level biology, variant consequence studies, or interaction proteomics will find this material most applicable. Species reactivity of matched reagents is validated for human and predicted for non-human primate, dog, and a range of mammalian species based on sequence homology. Researchers using this recombinant for antibody validation can pair it directly with the Triple Point Biologics matched antibody (SKU: RP-SerpinB11), available via the cross-linked product page.

Background

SERPINB11 encodes a cytoplasmic, non-inhibitory member of the clade B serpin family. While most serpins in this clade act as intracellular protease inhibitors protecting against misdirected proteolysis, Serpin B-11 is distinguished by sequence-level deviations in the reactive-centre loop and serpin scaffold that abolish the conformational change underpinning inhibitory function. Its physiological role remains an active area of investigation, and the recombinant protein provides a defined reagent for probing that biology. In oncology research, SERPINB11 expression has been studied as a prognostic marker in gynaecological malignancies. Park et al. (2021, In Vivo) characterised SERPINB11 expression in high-grade serous and clear cell carcinoma of the ovary, reporting associations between expression levels and patient prognosis — establishing a rationale for including recombinant Serpin B-11 as a standard in immunohistochemical and Western blot validation workflows targeting these tumour types. Separately, Lee et al. (2020, Cancers (Basel)) examined the functional consequences of SERPINB11 inhibition in epithelial ovarian cancer cell lines, demonstrating that the flavonoid eupatilin promotes cell death via calcium influx through an ER–mitochondria axis associated with SERPINB11 inhibition, positioning SERPINB11 as a research target in studies of ovarian cancer cell death pathways. Beyond oncology, SERPINB11 has attracted attention in the context of liver injury. Umman et al. (2022, Pediatr Nephrol) reported SERPINB11 variants in paediatric patients with Shiga toxin-producing E. coli haemolytic uraemic syndrome (STEC-HUS) presenting with liver injury, raising questions about genotype–phenotype relationships and variant consequence that recombinant protein reagents can help address in cell-free or cell-based assay systems. Whole-exome sequencing studies in indeterminate acute liver failure cohorts (Rakela et al., 2019, Clin Transl Gastroenterol) have similarly flagged SERPINB11 as a candidate gene warranting functional follow-up. SERPINB11 also appears in transcriptomic prostate cancer datasets; Treacy et al. (2023, Minerva Urol Nephrol) reported on Decipher score components in the context of PSA persistence after prostatectomy, where SERPINB11 expression features in the multi-gene signature — underscoring the utility of a well-characterised recombinant standard for validating detection reagents used in gene-expression-based studies. Across these published research contexts, recombinant Serpin B-11 produced in HEK293 provides a consistent, sequence-verified protein reference for antibody characterisation, dot-blot standards, pull-down input controls, and variant-consequence studies in both cancer biology and liver injury research.

Applications

  • Antibody validation positive control for Western blot (paired with RP-SerpinB11 matched antibody)
  • Antigen standard for IHC titration and scoring optimisation in ovarian carcinoma tissue sections
  • Dot-blot or slot-blot loading standard for quantitative expression studies
  • ELISA standard curve preparation for SERPINB11 quantification in cell lysates or conditioned media
  • Pull-down input control for identifying Serpin B-11 protein–protein interaction partners
  • Recombinant reference material for variant-consequence studies (wild-type comparator in cell-free assays)
  • Transcriptomic/proteomic correlation studies requiring a defined protein-level reference standard

References

  1. Treacy PJ et al. Decipher Score predicts prostate specific antigen persistence after prostatectomy. Minerva Urol Nephrol. 2023. doi:10.23736/S2724-6051.23.05395-8. PMID: 37728494.
  2. Umman N et al. SERPINB11 variant-related liver injury in STEC-HUS: case reports and literature review. Pediatr Nephrol. 2022. doi:10.1007/s00467-022-05602-5. PMID: 35552823.
  3. Park SJ et al. SERPINB11 Expression Is Associated With Prognosis of High-grade Serous and Clear Cell Carcinoma of the Ovary. In Vivo. 2021. doi:10.21873/invivo.12547. PMID: 34410952.
  4. Lee JY et al. Eupatilin Promotes Cell Death by Calcium Influx through ER-Mitochondria Axis with SERPINB11 Inhibition in Epithelial Ovarian Cancer. Cancers (Basel). 2020. doi:10.3390/cancers12061459. PMID: 32503295.
  5. Rakela J et al. Whole Exome Sequencing Among 26 Patients With Indeterminate Acute Liver Failure: A Pilot Study. Clin Transl Gastroenterol. 2019. doi:10.14309/ctg.0000000000000087. PMID: 31609742.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Secreted; blood plasma

Frequently Asked Questions

What molecular weight does recombinant Serpin B-11 run at on SDS-PAGE or Western blot?

The full-length 392-amino-acid human Serpin B-11 has a predicted molecular weight of approximately 44 kDa. On reducing SDS-PAGE, the recombinant protein (HEK293-expressed) typically migrates between 45–50 kDa — a modest upward shift from the calculated MW that is consistent with glycosylation or other post-translational modifications retained from mammalian expression. When running a Western blot positive control alongside the matched antibody RP-SerpinB11, expect the dominant band in this 45–50 kDa window. Any faint higher-MW band may represent SDS-resistant dimer.

Is Serpin B-11 a processed or cleaved form — does the recombinant cover the full sequence?

Serpin B-11 (UniProt Q96P15) is annotated as a single 392-residue chain with no classical signal peptide and no documented propeptide cleavage, consistent with its clade B (cytoplasmic) classification. This recombinant covers the full 392-residue sequence expressed in HEK293 cells. There are no well-characterised isoforms arising from alternative cleavage in the literature; the intact native-length form is therefore the biologically relevant species for conformation, interaction, and localisation studies. We are not aware of a cleaved active form analogous to the stressed/latent transitions seen in inhibitory serpins.

Does Serpin B-11 inhibit serine proteases — what protease substrates should I use to test activity?

Serpin B-11 is annotated as a non-inhibitory serpin: structural divergence within its reactive-centre loop is thought to prevent the canonical stressed-to-relaxed conformational transition required for covalent serine protease inhibition. Standard chromogenic substrates used for inhibitory serpins (e.g., pNA-conjugated substrates for trypsin, elastase, or thrombin) are not appropriate for functional readout here. Assay design should focus on non-inhibitory functions — protein–protein interaction assays, thermal shift/DSF for conformational stability studies, or cell-based binding assays — rather than classical protease inhibition kinetics.

What buffer conditions are recommended for Serpin B-11 recombinant protein in binding or interaction assays?

The protein is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol — a buffer that supports folded, soluble serpin conformation and is compatible with most pull-down, co-IP, and SPR setups. For interaction assays requiring lower glycerol, the protein can be diluted into assay buffer (PBS pH 7.4 or HEPES-based buffers at comparable ionic strength); keep glycerol ≥2% if the working concentration drops below ~0.1 mg/mL to reduce surface adsorption. Avoid pH below 6.5, as clade B serpins can undergo acid-induced conformational change to the latent form.

What starting concentration should I use for recombinant Serpin B-11 in a protein interaction or thermal shift assay?

For differential scanning fluorimetry (DSF/thermal shift), 2–5 µg per reaction (~0.5–1 µM based on the ~44 kDa MW) is a practical starting point alongside SYPRO Orange at 5× final concentration. For pull-down or co-IP bait loading, 5–10 µg of recombinant Serpin B-11 per condition is typical for a first experiment, titrating prey protein 1:0.5–1:5 molar ratio relative to bait. Purity is >90–95% by SDS-PAGE and endotoxin is <0.1 EU/µg, so cell-based binding assays at 0.1–1 µM extracellular concentrations are feasible without LPS-driven confounds.

Can I use recombinant Serpin B-11 as a positive control for Western blot with the RP-SerpinB11 antibody?

Yes — this is the primary validated use case for pairing REC-SerpinB11 with RP-SerpinB11. The rabbit polyclonal antibody was raised against the same human Serpin B-11 sequence and has been validated by Western blot, so recombinant protein loaded alongside cell lysate provides a defined-MW band at 45–50 kDa for antibody performance confirmation. Load 20–50 ng of recombinant protein per lane; this gives a clean, strong band without saturating the signal at standard ECL exposures. The matched antibody product page (/anti-serpin-b11-rabbit-polyclonal-antibody) lists recommended antibody dilutions for co-use.

How much recombinant Serpin B-11 should I load for antibody validation or positive control on a Western blot?

A titration of 10 ng, 25 ng, and 50 ng per lane is a useful starting range for RP-SerpinB11 antibody validation experiments. At 50 ng you are loading roughly 1 pmol of the ~44 kDa protein, which is well within the linear detection range for most HRP-conjugated secondary antibody and ECL systems. If you are validating alongside endogenous Serpin B-11 in cell lysates — noting that expression appears tissue-restricted — include the recombinant lane as a MW anchor. Avoid loading >200 ng, as excess recombinant serpin can bleed into adjacent lanes on standard mini-gels.

How should I store recombinant Serpin B-11 and what is its shelf life after thawing?

Store at -20°C in the supplied single-use aliquots. Avoid repeated freeze-thaw cycles, as serpins are susceptible to polymerisation under thermal stress — a well-documented artefact for the serpin superfamily. Once thawed, keep on ice and use within 4–8 hours; if same-day use is not possible, the thawed aliquot can be held at 4°C for up to 24 hours without significant aggregation, provided it is not agitated. Unopened aliquots stored continuously at -20°C are stable for at least 12 months from the date of manufacture. Do not dilute into buffer lacking glycerol for long-term storage.

Validation imagery coming soon

Western blot validation figures for REC-SerpinB11 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →